O'Shaughnessy Asset Management’s Novavax NVAX Stock Holding History

O'Shaughnessy Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-672	Closed	-$140K	–	2055
2021 Q3	$140K	Buy	672 +32	+5%	+$7.05K	﹤0.01%	1209
2021 Q2	$136K	Sell	640 -124	-16%	-$22.7K	﹤0.01%	1199
2021 Q1	$138K	Buy	764 +87	+13%	+$17.3K	﹤0.01%	1072
2020 Q4	$75K	Sell	677 -1,430	-68%	-$152K	﹤0.01%	1154
2020 Q3	$229K	Buy	+2,107	New	+$257K	0.01%	657

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

O'Shaughnessy Asset Management's NVAX Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Novavax (NVAX) in Q4 2021, closing a stake of 672 shares — an estimated $140K sold.

O'Shaughnessy Asset Management first reported a position in NVAX in Q3 2020 and held it in 5 quarters. The position peaked at $229K in Q3 2020. 429 funds tracked by Wall St. Rank hold NVAX as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Novavax position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 672 Novavax shares in Q4 2021, an estimated $140K.
O'Shaughnessy Asset Management first reported a position in Novavax in Q3 2020 and held it in 5 quarters.
O'Shaughnessy Asset Management's Novavax position peaked at $229K in Q3 2020.
429 funds tracked by Wall St. Rank held Novavax as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.